Kotak Institutional Equities has issued a resounding BUY call on Crompton Greaves Consumer, setting a fair value target of Rs 410 against the current market price of Rs 344.
Glenmark Pharmaceuticals has seized the spotlight within India’s pharmaceutical landscape, propelled by a record-breaking global licensing agreement for its flagship oncology asset.
Kotak Institutional Equities has issued a BUY recommendation on InterGlobe Aviation (IndiGo), underscoring the carrier’s strategic prowess in capacity planning, international expansion, and differe
Motilal Oswal Securities has reiterated a BUY call on Lodha Developers, projecting a robust 36% upside with a revised target price of Rs 1,870 per share.